Patents Assigned to Biolotus Biotechnology AG
  • Highly pure pentamycin
    Patent number: 9090582
    Abstract: Described is pentamycin in a purity exceeding 95%, certain polymorphs and solvates of pentamycin, processes for their manufacture, and a method for decreasing the rate of degradation of pentamycin.
    Type: Grant
    Filed: July 22, 2013
    Date of Patent: July 28, 2015
    Assignee: Biolotus Biotechnology AG
    Inventors: Karl Reuter, Victor Meier, Florian Stolz, Dieter Krimmer, Cees Winninps
  • HIGHLY PURE PENTAMYCIN
    Publication number: 20140094602
    Abstract: Described is pentamycin in a purity exceeding 95%, certain polymorphs and solvates of pentamycin, processes for their manufacture, and a method for decreasing the rate of degradation of pentamycin.
    Type: Application
    Filed: July 22, 2013
    Publication date: April 3, 2014
    Applicant: Biolotus Biotechnology AG
    Inventors: Karl REUTER, Victor Meier, Florian Stolz, Dieter Krimmer, Cees Winninps
  • Highly pure pentamycin
    Patent number: 8519162
    Abstract: Described is pentamycin in a purity exceeding 95%, certain polymorphs and solvates of pentamycin, processes for their manufacture, and a method for decreasing the rate of degradation of pentamycin.
    Type: Grant
    Filed: March 20, 2009
    Date of Patent: August 27, 2013
    Assignee: Biolotus Biotechnology AG
    Inventors: Karl Reuter, Viktor Meier, Florian Stolz, Dieter Krimmer, Cees Winninps